SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is drawing attention for holding support and showing relative strength against a weak semiconductor group, with traders positioning for a potential rebound ahead of its scheduled earnings report. Bullish technical and options chatter contrasts with skepticism about the stocks recent slide and uncertainty around the earnings outlook and reported job cuts.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Discussion centers on the possibility that U.S. regulators could temporarily allow compounding of certain peptides, which traders see as a potential new market for Hims & Hers, though no approval is confirmed. Optimism about that prospect and upcoming earnings contrasts with frustration over repeated failed breakouts, a long-running trading range, and regulatory concerns.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FUBOs steep, thin-volume selloff dominates discussion, with traders debating technical and short-selling pressure versus concerns about the business as they await earnings and the new CEOs strategic plan. Bulls cite Disney integration and expanded regional sports distribution, while bears point to subscriber growth, dilution, and execution risks.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is drawing attention amid a broad cybersecurity-sector rally, with traders citing firmer enterprise security budgets and concerns about AI-related threats and newly publicized software vulnerabilities. Momentum-focused bulls see the move as renewed demand for cyber protection, while others caution that high valuations and upcoming earnings could make the rally vulnerable to a pullback.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Mercks BRUNELLO results are drawing attention as clinical support for Wnt activation in retinal disease, which traders see as relevant to Surrozens Wnt-based eye-drug pipeline and linked to the stocks sharp move. The FDA clearance of SZN-8141s IND and related financing are also in focus, alongside debate over dilution, the lack of human efficacy data, and whether the rally can hold.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys technical rebound and repeated tests of resistance are driving attention, with bullish traders citing improving momentum and call setups ahead of earnings. Others question whether the stock can sustain a breakout and are watching for another rejection or pullback.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Unconfirmed takeover chatterparticularly speculation about an unnamed West Coast technology buyer making an all-stock bid, with traders often guessing Metais dominating discussion. Many see a potential deal as a catalyst, while skeptics note that no offer is confirmed and point to upcoming earnings and PayPals turnaround as the more concrete tests.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A reported exploit affecting NEAR Intents and emergency isolation of connected chains have sparked concern about security and trust in the protocols cross-chain activity. Traders are split between fearing lasting damage to NEARs growth thesis and treating the selloff as a buying opportunity.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Attention centers on Candels clinical pipeline, including upcoming SITC presentations on CAN-2409 in NSCLC and CAN-3110 in glioblastoma, and the planned prostate-cancer BLA submission. Bulls view the data and regulatory milestone as potential catalysts, while skeptics focus on the share-price decline, weak trading volume, dilution risk, and the CEOs share sales.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention after a steep share-price decline as investors question Auvelitys commercial rollout for Alzheimers-related agitation and whether prescription growth will support expectations. Traders disagree over whether reported scripts understate demand because of samples and long-term-care channels or signal slower uptake; many are looking to the upcoming Q3 results for clearer sales and profitability evidence, while managements silence adds to uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RBC maintains Calfrac stock with CAD$5.00 target amid EBITDA miss

Investing.com -- On Thursday, RBC (TSX:RY) Capital Markets analyst Keith Mackey reiterated a Sector Perform rating for   Calfrac Well Services Ltd  . (TSX:CFW) with a price target of CAD$5.00, despite expressing a negative sentiment following the company's fourth-quarter results. Calfrac's adjusted EBITDA for the quarter was $35 million, falling short of both street and RBC's expectations by 15% and 19%, respectively, due to weaker performance in North America.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

CFW Fundamentals